4//SEC Filing
Scranton Richard 4
Accession 0001209191-19-056090
CIK 0001396814other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 5:10 PM ET
Size
12.7 KB
Accession
0001209191-19-056090
Insider Transaction Report
Form 4
Scranton Richard
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2019-11-08$25.37/sh+4,750$120,508→ 35,509 total - Exercise/Conversion
Common Stock
2019-11-08$10.81/sh+14,698$158,885→ 30,759 total - Sale
Common Stock
2019-11-08$45.00/sh−19,448$875,160→ 16,061 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-11-08−14,698→ 0 totalExercise: $10.81Exp: 2022-06-05→ Common Stock (14,698 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2019-11-08−4,750→ 20,250 totalExercise: $25.37Exp: 2023-03-05→ Common Stock (4,750 underlying)
Footnotes (2)
- [F1]The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]The stock options are fully vested.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001709330
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 5:10 PM ET
- Size
- 12.7 KB